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 2 
SUMMARY 21 
Shigella is a Gram-negative bacterium that causes bacillary dysentery worldwide. It 22 
invades the intestinal epithelium to elicit intense inflammation and tissue damage, yet 23 
the underlying mechanisms of its host selectivity and low infectious inoculum remain 24 
perplexing. Here we have reported that Shigella co-opts human α-defensin 5 (HD5), a 25 
host defense peptide important for intestinal homeostasis and innate immunity, to 26 
enhance its adhesion to and invasion of mucosal tissues. HD5 promoted Shigella 27 
infection in vitro in a structure-dependent manner. Shigella, commonly devoid of 28 
effective host-adhesion apparatus, preferentially targeted HD5 to augment its ability to 29 
colonize the intestinal epithelium through interactions with multiple bacterial membrane 30 
proteins. HD5 exacerbated infectivity and Shigella-induced pathology in a culture of 31 
human colorectal tissues and three animal models. Our findings illuminate how Shigella 32 
exploits innate immunity by turning HD5 into a virulence factor for infection, unveiling a 33 
mechanism of action for this highly proficient human pathogen. 34 
 35 
36 
 3 
INTRODUCTION 37 
Intestinal colonization and epithelial adhesion is a crucial early event in the 38 
pathogenesis of many enteropathogens, which can then enable bacterial invasion of 39 
host epithelial cells and disseminated infection (Cossart and Sansonetti, 2004; 40 
Donnenberg, 2000; Pizarro-Cerdá and Cossart, 2006). Most enterobacteria use 41 
fimbriae, an adhesive filamentous organelle protruding from the outer-membrane 42 
surface of Gram-negative bacteria, for host attachment (Choudhury et al., 1999; Kline et 43 
al., 2009; Li et al., 2009). Paradoxically, Shigella, the etiological agent of bacillary 44 
dysentery, lacks such adhesion machinery in general, yet it is a remarkably infectious 45 
and contagious enteropathogen that invades and elicits intense inflammation and tissue 46 
damage of the colorectal epithelium (Carayol and Tran Van Nhieu, 2013; Perdomo et 47 
al., 1994; Phalipon and Sansonetti, 2007; Schroeder and Hilbi, 2008). Despite a 48 
continued search for mechanisms of adhesion, the question of how Shigella has 49 
acquired extraordinary infectivity without a highly efficient and more general host 50 
adhesion apparatus remains unanswered. In studying the mode of action of 51 
antimicrobial peptides against Shigella, we found that when the human enteric α-52 
defensin 5 (HD5), an abundant and important host protective molecule produced by 53 
Paneth cells of the small intestine (Bevins and Salzman, 2011), binds Shigella, it 54 
augments infectivity via enhanced bacterial adhesion to and subsequent invasion of 55 
epithelial cells and tissues. We posited that Shigella subverts innate host defense to 56 
colonize and destroy the intestinal epithelium by turning HD5 into a molecular 57 
accomplice that imparts its infectivity and host selectivity. 58 
 59 
 4 
RESULTS 60 
HD5 promotes Shigella infection of epithelial cells in vitro. Antimicrobial peptides, 61 
expressed primarily in phagocytes and epithelia, play critical roles in host immune 62 
defense against pathogenic infection often through microbicidal activity (Bevins and 63 
Salzman, 2011; Ganz, 2003; Lehrer and Lu, 2012; Selsted and Ouellette, 2005; Zasloff, 64 
2002). To study the role of antimicrobial peptides in Shigella pathogenesis, we tested a 65 
panel of six human and two murine defensin peptides against the Shigella flexneri strain 66 
Sf301 in an in vitro antibacterial activity assay (Ericksen et al., 2005; Mastroianni and 67 
Ouellette, 2009), including human neutrophil alpha-defensin 1 (HNP1), enteric alpha-68 
defensins 5 and 6 (HD5 and HD6), beta-defensins 2 and 3 (HBD2 and HBD3), the 69 
cathelicidin peptide LL-37, and murine alpha-defensins (cryptdins) 3 and 4 (Crp3 and 70 
Crp4). While most of the human antimicrobial peptides displayed varying but weak 71 
bactericidal activity at low micromolar concentrations, HD6 and the two cryptdins 72 
showed little killing (Fig. S1A). Weak antibacterial activity was also observed for HD5 73 
with the Shigella sonnei strain Ss86 and five clinical isolates (Fig. S1B). To test whether 74 
this antibacterial activity correlated with the ability of these peptides to inhibit Shigella 75 
infection in vitro, we quantified bacterial adhesion, invasion and intracellular replication 76 
in a conventional infection assay using HeLa cells (Fig. S2). When added to Sf301, two 77 
human alpha-defensins, HNP1 and HD5, enhanced Shigella adhesion to and invasion 78 
of HeLa cells in an inoculum-dependent manner, with the enteric alpha-defensin HD5 79 
being markedly more active than its neutrophil counterpart HNP1 (Fig. 1A-B). In fact, 80 
HD5 at 2 μM enhanced bacterial adhesion or invasion by more than 30-fold. Our 81 
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subsequent study thus focused on HD5 not only for its site of abundant expression 82 
relevant to Shigella infection, but also for its superior infection-enhancing activity. 83 
Dissection of time-dependent cellular events in Shigella infection further revealed 84 
that HD5 acted early, predominantly at the bacterial infection step (adhesion and 85 
invasion) rather than on intracellular replication (Fig. 1C-D). Similar results were 86 
obtained for HD5 with Shigella sonnei and also multiple clinical isolates (Fig. S1C-D). 87 
Consistent with these findings, immunofluorescence and scanning electron microscopy 88 
(SEM) studies showed that HD5-treated GFP-expressing or unlabeled Sf301 clustered 89 
on the surface of HeLa cells within 10 min of bacteria and HeLa coincubation (Fig. 1E). 90 
To verify the viability of adhered Shigella, we transformed mCherry-labeled Sf301 (red) 91 
with a reporter plasmid that expresses GFP (green) when the type 3 secretion system 92 
(T3SS) is activated upon host cell contact (Campbell-Valois et al., 2014), an obligate 93 
step in Shigella invasion, and found that HD5 treatment turned many clustered bacteria 94 
yellow (colocalized green and red) within 60 min of coincubation with HeLa cells (Fig. 95 
1F). Without host cells, HD5 alone failed to change the color of bacteria as illustrated in 96 
Figs. 1F and S1G, suggesting that it did not activate the T3SS directly. Furthermore, 97 
HD5 was found to promote strong adhesion of Shigella even when the type III secretion 98 
system (T3SS), responsible for bacterial invasion and virulence, was inactivated either 99 
transcriptionally at low growth temperature (Maurelli et al., 1984) or genetically by 100 
deletion of spa33 encoding an essential component of the T3SS (Morita-Ishihara et al., 101 
2006) (Fig. S1E). In addition, HD5-enhanced Shigella infection was not restricted to 102 
HeLa cells, albeit the standard in vitro infection model for Shigella (Philpott et al., 2000), 103 
as a wide variety of epithelial cell lines of different species and/or tissue origins were 104 
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found equally susceptible (Fig. S1F and Table S1). Taken together, these results 105 
indicate that HD5 promoted Shigella infection in vitro by enhancing bacterial adhesion to 106 
epithelial cells, leading to increased bacterial invasion.  107 
HD5 promotes Shigella infection in vivo. The impact of HD5 on the in vivo 108 
invasiveness of Shigella was extensively examined in three different animal models: (1) 109 
cornea infection in guinea pigs (the classic "Sereny test") (Sereny, 1955), (2) colon 110 
infection in guinea pigs (Arena et al., 2015; Shim et al., 2007), and (3) ileum and colon 111 
infection in mice (Sawasvirojwong et al., 2013). For the Sereny test, Sf301 was 112 
inoculated in the eye at a density of 1x106 CFU/eye, together with HD5 at 0, 4, and 8 113 
μM; the severity of infection graded from 1 to 3 was scored daily for one week (Fig. 114 
S3A). Eye infection worsened over time with the symptoms developing much more 115 
rapidly in the HD5-treated groups than the control group. As shown in Fig. 2A, in the 116 
absence of HD5, three out of fifteen animals developed full-blown keratoconjunctivitis 117 
and one showed signs of mild irritation, after one week.  By sharp contrast, in the 118 
presence of 4 μM HD5 the number of animals with high grade keratoconjunctivitis 119 
increased to 6 in just three days (Fig. S3A) and to 11 (of 15) in one week, and three 120 
animals died in the group treated with 8 μM HD5. Of note, treatment with HD5 alone at 121 
8 μM had no adverse effects on the animals (Fig. 2A). These data support that HD5 122 
facilitated bacterial adhesion to and invasion of corneal epithelial cells in guinea pigs. 123 
In a second guinea pig model, anaesthetized animals were inoculated 124 
intrarectally with 1x108 CFU of HD5-treated, 1x108 CFU of mock-treated, 1x109 CFU of 125 
mock-treated GFP-expressing Sf301 in 200 μl medium, or medium alone at equal 126 
volume (negative control). Animals were euthanized at 4, 8, 24 and 48 h post-challenge, 127 
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and the distal 10 cm of colon tissue was harvested for quantitative fluorescence imaging 128 
of Shigella infection as previously described (Arena et al., 2015). Analysis of tissue-129 
associated bacteria revealed that HD5-treated Shigella achieved a much greater early 130 
adhesion and colonization (at both 4 and 8 h post-challenge time points), when 131 
compared to the corresponding 1x108 CFU of mock-treated bacteria, but also when 132 
compared to a higher inoculum (1x109 CFU) of mock-treated bacteria (Figs. 2B-C, S3B). 133 
SEM imaging corroborated these results by showing extensive colonization of colonic 134 
crypts by HD5-treated Shigella (Fig. 2D). 135 
Histological changes by bacterial infection in the colon at the later time points (24 136 
h and 48 h) were examined by HE staining (Fig. 2E-G). All Shigella-inoculated animals 137 
showed some evidence of histopathology at 24 h and 48 h post-challenge, albeit to 138 
different extents. Without HD5 treatment, 1x108 CFU of Sf301 caused mild disruption of 139 
luminal surface adjacent to the initial inoculating site 24 h post-challenge, whereas 140 
1x109 CFU caused much more severe tissue damage during the same time period. HD5 141 
potentiated the tissue damage caused by 1x108 CFU of Sf301, characterized by 142 
thickened submucosa and disruption of mucosal and submucosal layers, with edema, 143 
erosion, and crypt distortion comparable to 1x109 CFU. By 48 h after initial inoculation, 144 
most of the histopathology caused by 1x108 CFU of Sf301 inoculum had healed, and the 145 
integrity of mucosa was almost restored. In contrast, the infection by 1x108 CFU of HD5-146 
treated Sf301 bacteria showed worsened pathology at 48 h, comparable to infection 147 
with 10-fold higher inoculum (1x109 CFU) Sf301 Shigella. The initial infection loci 148 
expanded and there was nearly complete destruction of mucosal and submucosal 149 
layers. Moreover, rather than a single major infection locus caused by Sf301 bacteria in 150 
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each animal of the mock treated groups, multiple (3-5) infection loci were identified in 151 
colonic tissue of each animal infected by HD5-treated Shigella 48 h post-challenge. 152 
These data are consistent with the conclusion that HD5-treated Shigella disseminated 153 
more extensively along the colonic tissue mucosa within 8 h after initial inoculation than 154 
did mock-treated Sf301 bacteria. Of note, core body temperature of challenged animals, 155 
a representative sign of bacillary dysentery, showed a dramatic HD5-dependent effect. 156 
While inoculation of 1x108 CFU of mock-treated Sf301 Shigella resulted in a marginal 157 
increase in body temperature within 48 h, 1x108 CFU of HD5-treated bacteria caused 158 
severe fever in inoculated animals (an average increase by 1.3 C) from 24 h, 159 
comparable to the high-inoculum (1x109 CFU) group (Fig. 2H).  160 
To extend the findings from the two guinea pig models, we adopted a well-161 
established murine ileal and colonic loop model to investigate the impact of HD5 on the 162 
in vivo colonization and pathogenesis of Shigella (Sawasvirojwong et al., 2013). 163 
Analysis of tissue-associated bacteria in mouse colonic and ileal loops confirmed that 164 
HD5-treated Shigella was much more robust in adhesion and colonization than mock-165 
treated bacteria (Fig. 2I-J). Taken together, our findings from three different animal 166 
models provide compelling evidence that HD5 can promote Shigella infection in vivo by 167 
enhancing bacterial adhesion to and invasion of epithelial tissues. 168 
HD5 exacerbates Shigella-elicited human tissue damage ex vivo. Human colorectal 169 
explants were cultured as an ex vivo model to further investigate the role of HD5 in 170 
pathogenesis with human tissue (Fig. S3C). SEM analysis revealed that HD5 171 
significantly enhanced the adhesion of clustered Shigella cells to the colonic mucosa 172 
(Fig. 3A-B). Histologically, human colonic tissues mock-treated with medium or treated 173 
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with HD5 alone at 8 μM displayed an intact lumenal epithelial layer and normal tissue 174 
architecture (Fig. 3C-D). In the absence of HD5, samples inoculated with Shigella 175 
(1x106 CFU) showed disruption of the lumenal surface of epithelia, but the tissue 176 
architecture was largely maintained (Fig. 3C-D). Co-inoculation of Shigella and HD5 led 177 
to a complete destruction of not only the epithelium, but also its underlying tissue 178 
structure (Fig. 3D). These results indicate that Shigella was capable of invading the 179 
human colonic epithelium and did so much more efficiently in the presence of HD5, thus 180 
further corroborating the proposed model of pathogenesis. 181 
To provide additional support of the ex vivo study, we established an in vitro 182 
infection model using a polarized epithelial monolayer of human Caco-2 cells as 183 
previously described (Mounier et al., 1992). As shown in Fig. 4A, addition of 8 μM HD5 184 
to the Caco-2 monolayer had limited impact over a period of 24 h on its integrity and 185 
permeability as measured by trans-epithelial electrical resistance (TEER). While 186 
Shigella alone was slowly destructive, a dramatically accelerated disintegration of the 187 
monolayer was evident in the presence of HD5. In fact, at 6 h, HD5 treatment increased 188 
intracellular CFU by over 300-fold (compared with the mock treatment group) due 189 
presumably to highly efficient bacterial invasion and cell-cell spreading of amplifying 190 
Shigella (Fig. 4B). These results are consistent with fluorescence and SEM imaging 191 
studies showing that HD5 potentiated Shigella destruction of the tight junction of the 192 
epithelium (Fig. 4C). 193 
Human luminal fluids from the small intestine promote Shigella infection in vitro. 194 
When maximally secreted, the concentration of HD5 in the lumen of the small intestine 195 
is estimated to be in the millimolar range (Ayabe et al., 2000; Ghosh et al., 2002; 196 
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Ouellette, 2011). However, unstimulated the quantity of HD5 is far lower in aspirated 197 
small intestinal fluids from healthy donors undergoing routine screening colonoscopy, in 198 
part due to the large volumes of electrolyte solution to enable sampling. When such 199 
clinical aspirates collected from 17 individuals were analyzed directly, none were found 200 
active in enhancing Shigella adhesion to and invasion of HeLa cells in vitro. When 201 
concentrated and tested for activity in the infection assay, the ileal fluids became active 202 
in promoting Shigella infection in vitro (Fig. 4D-E). The infection-enhancing activity was 203 
largely neutralized by anti-HD5 serum, indicating that HD5 in human luminal fluids from 204 
the small intestine contributed to Shigella infection in vitro. In addition, if prior to 205 
concentration exogenous HD5 (4 μM) was added to the intestinal fluid samples, they 206 
gained the ability to promote Shigella infection (Fig. S3E), albeit to various degrees.  207 
These data support that the activity shown for 1-8 µM concentrations of HD5 in the in 208 
vitro and in vivo models of Shigella infection reported in the current investigation reflects 209 
similar activity reasonably anticipated during clinical infection in the human intestine. 210 
Structural basis of HD5-enhanced Shigella infection. The primary structures of 211 
epithelial defensins vary remarkably from species to species (Bevins and Salzman, 212 
2011; Ganz, 2003; Lehrer and Lu, 2012; Selsted and Ouellette, 2005).  To elucidate the 213 
structural basis underlying HD5-promoted Shigella infection of host cells, we functionally 214 
analyzed a panel of 23 analogs of HD5 in an infection assay using Sf301 and HeLa 215 
cells (Fig. 5A-B). Our data showed that: (1) the native tertiary structure of HD5 was 216 
absolutely required, as replacement of the six Cys residues by isosteric aminobutyric 217 
acid (Abu) to remove the three intra-molecular disulfide bonds of HD5 abolished 218 
adhesion and invasion enhancement; (2) while native HD5 readily dimerizes, the 219 
 11 
dimerization-debilitating analog E21Me-HD5, where the amide peptide bond is 220 
methylated at Glu21 to impair HD5 dimerization (Rajabi et al., 2012), was largely 221 
inactive in promoting Shigella infection; (3) Ala replacement of bulky hydrophobic 222 
residues, particularly those in the C-terminal region of HD5, such as Leu26, Tyr27 and 223 
Leu29, was functionally detrimental; (4) Arg28 was a key residue for activity, although 224 
the other cationic Arg residues were functionally dispensable. Because Tyr27 and 225 
Arg28 appeared to be critically important residues, we crystallized both Y27A-HD5 and 226 
R28A-HD5 and determined their structures to 1.75 and 2.4 Å, respectively (Fig. 5C-D). 227 
The functionally inactive Y27A-HD5 existed as a monomer (Fig. 5E), consistent with the 228 
fact that this residue, but not Arg28, is part of a contiguous hydrophobic core (along with 229 
Leu29) mediating HD5 dimerization. The R28A-HD5 formed a canonical dimer similar to 230 
wild-type HD5 (Fig. 5F), but was inactive, indicating dimerization alone was not 231 
sufficient for activity. Rather, for the importance of Arg28, mutational and structural 232 
analysis identified two amphipathic surfaces in the HD5 dimer (Fig. 5G), comprising 233 
residues Leu16, Val19, Leu26 and Arg28, which likely operate in tandem in interactions 234 
with molecular and cellular targets of the defensin. Taken together, these results 235 
highlight hydrophobicity and selective cationicity that are structurally segregated in a 236 
stable dimer as the most important molecular determinants of HD5 function. Of note, 237 
these structure-function determinants are in agreement with previous studies of 238 
antibacterial and antiviral activities of HD5 (Lehrer and Lu, 2012; Rajabi et al., 2012; 239 
Tenge et al., 2014). 240 
Fimbria deficiency in Shigella confers its sensitivity to HD5-mediated 241 
enhancement in bacterial infection. Type I fimbriae are the major components that 242 
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impart host adhesiveness for many enterobacteria such as E. coli and Salmonella 243 
(Edwards and Puente, 1998; Jones et al., 1995; Pizarro-Cerdá and Cossart, 2006), yet 244 
they are conspicuously absent from most Shigella strains, including Sf301 and many 245 
clinical isolates, due to independent mutations in the fim gene clusters (Bravo et al., 246 
2015; Snellings et al., 1997). To investigate the role of fimbriae in HD5-enhanced 247 
Shigella infection, we restored fimbria production in Sf301 by expressing the fim 248 
cassette from E. coli JM103 (Fig. 6A). While fimbria-expressing Sf301 showed much 249 
stronger basal adhesion to HeLa cells than wild-type Sf301, its improved adhesion 250 
capacity became largely insensitive to HD5 treatment (Fig. 6B). Results paralleling 251 
these were found for E. coli BL21, the fimbria-deficient counterpart of JM103 of the 252 
same genetic background, as well as the fimA-deleted strain JM103 ΔfimA (Fig. 6C). 253 
Similar to observations with Shigella, the fimbria-expressing E. coli showed stronger 254 
basal adhesion to HeLa cells, but the enhanced adhesion became largely insensitive to 255 
HD5 treatment. Consistent with these results, HD5 promoted a substantial increase in 256 
adhesion to HeLa cells of the mutant strain SNP494 of Salmonella enterica serovar 257 
Typhimurium, whose fimbria and flagella were deleted (Chu et al., 2012), despite a 258 
lower basal adhesion level as compared with its wild type counterpart IR715 (Fig. S4H-259 
I). Taken together, our findings demonstrate that although fimbria deficiency in Shigella 260 
conferred its poor ability to adhere intrinsically, this deficiency greatly augmented the 261 
ability for HD5 to mediate adhesion to host epithelial cells. 262 
HD5 targets multiple bacterial membrane proteins to promote Shigella adhesion 263 
to host cells.  To better understand the mechanism of HD5-mediated adherence, we 264 
found that in the presence of HD5, Shigella preferably attached to the periphery of 265 
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adhered, but not suspended, host cells, where the dynamic cell-substratum contacts 266 
occur (Fig. S4A-C). siRNA silencing studies coupled with immunofluorescence staining 267 
suggest that integrins are involved as host factors in HD5-promoted Shigella adhesion 268 
(Fig. S4D-G), consistent with their known ability to interact with α-defensins (Chavakis 269 
et al., 2004; Economopoulou et al., 2005). These findings notwithstanding, HD5 270 
primarily targeted the pathogen rather than host cells to enhance infection. Although 271 
HD5 can bind to both host and bacterial cells efficiently (Fig. S5A), HD5 was 272 
substantially more effective in promoting bacterial infection when pre-incubated with 273 
Sf301, compared to pre-incubation with HeLa cells (Fig. 5D). SEM, TEM and 274 
immunogold-TEM studies revealed that HD5, but not its unstructured analog Abu-HD5, 275 
bound to the Shigella surface and formed patches of an “adhesive” structure, leading to 276 
the clustering of Shigella cells and their adhesion to host cells (Fig. 6E-F, S5B). 277 
To identify the bacterial targets with which HD5 directly interacts, we first 278 
investigated whether HD5, a known lectin capable of binding to glycosylated proteins 279 
(Lehrer et al., 2009), could interact with the bacterial LPS to promote host adhesion by 280 
characterizing several LPS truncation mutants of Sf301. Our data (Fig. S6A-C), 281 
however, showed that LPS was not targeted by HD5 for bacterial adhesion promotion. 282 
We next focused on potential proteinaceous targets of HD5 on the Shigella surface. 283 
Trypsin is the proteolytic processing enzyme of pro-HD5 and mature HD5 is stable to its 284 
hydrolytic activity (Ghosh et al., 2002). Pre-treatment of Sf301 with trypsin, while 285 
maintaining bacterial viability, lost HD5-augmented host adhesion capacity (Fig. S6D-286 
E), consistent with a proteinaceous target. HD5 enhanced bacterial adhesion to host 287 
cells within minutes of co-incubation, thus likely targeting preexisting surface 288 
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components without involving the de novo protein synthesis and/or membrane shuttling 289 
machinery – a notion also supported by an adhesion assay using heat and 290 
paraformaldehyde-inactivated Sf301 (Fig. S6G-H). 291 
Using the λ red mutagenesis system (Datsenko and Wanner, 2000), we 292 
genetically ablated Spa33, an essential component of the T3SS (Morita-Ishihara et al., 293 
2006), IcsA, an autotransporter protein reported to function as an adhesin in 294 
hyperadhesive Shigella flexneri mutants lacking the T3SS component IpaD 295 
(Brotcke Zumsteg et al., 2014), and three most abundant outermembrane proteins, 296 
OmpA, OmpC and OmpF (Ambrosi et al., 2012; Bernardini et al., 1993). Deletion of 297 
Spa33, IcsA, OmpA or OmpC in Sf301 led uniformly to a moderate drop in HD5-298 
mediated adhesion (Fig. 6G), except for OmpF whose expression in Sf301 was 299 
undetectable (Fig. S6F). As expected, a double genetic ablation of a combination of 300 
Spa33, OmpA and OmpC, and ΔOmpAΔOmpC in particular, further reduced bacterial 301 
adhesion. OmpC expression via plasmids not only restored adhesion of the OmpC-null 302 
mutant above that of the wild-type, but also increased HD5-mediated adhesion of the 303 
wild-type, OmpA-null and OmpF-null strains (Fig. 6G). Thus, our data indicate that 304 
multiple bacterial surface proteins collectively contributed to HD5-mediated adhesion. 305 
 306 
DISCUSSION 307 
The human α-defensin HD5 contributes to innate host defense against enteropathogens 308 
in the gut (Bevins and Salzman, 2011; Chu et al., 2012; Salzman et al., 2003), and 309 
helps maintain intestinal homeostasis by forming a chemical barrier that segregates the 310 
gut microbiota from host epithelium to limit tissue inflammation and microbial 311 
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translocation (Belkaid and Hand, 2014; Bevins and Salzman, 2011). Our biochemical 312 
and structural data, mechanistic and functional studies at the molecular and cellular 313 
levels, and in vivo and ex vivo findings all support that Shigella exploits HD5 for 314 
virulence and host infection. These results highlight that host defense factors such as α-315 
defensins, which are vitally host protective (Bevins and Salzman, 2011; Selsted and 316 
Ouellette, 2005; Zasloff, 2002), can be important contributors to pathogenesis when 317 
exploited by pathogens. Our work thus provides a noteworthy example of how immunity 318 
can serve as a “double-edged sword” in health and disease (Hansson and Libby, 2006). 319 
Our findings not only shed light on how Shigella adheres to and invade host cells 320 
despite its lack of fimbriae, but also offer a clue on host-range selectivity of Shigella 321 
infection. Enteropathogens such as Salmonella and E. coli have a sophisticated 322 
adhesion apparatus, including fimbriae, flagella and other adhesins to ensure efficient 323 
bacterial colonization of the intestinal epithelium and subsequent invasion and infection 324 
(Donnenberg, 2000; Pizarro-Cerdá and Cossart, 2006). Shigella, on the contrary, lacks 325 
such adhesion machinery in general (Bravo et al., 2015; Schroeder and Hilbi, 2008) and 326 
has a poor inherent ability to colonize host epithelium in vitro, confounding its 327 
extraordinary in vivo infectivity – 10-100 bacterial cells are sufficient to induce clinical 328 
symptoms in humans (DuPont et al., 1989). Despite recent reports of two adhesion 329 
molecules of Shigella, IcsA and MAM, which operate only in specific biological settings 330 
(Brotcke Zumsteg et al., 2014; Mahmoud et al., 2016), no efficient and general Shigella 331 
adhesin has been reported thus far. In fact, Shigella had long been thought to initially 332 
breach intestinal epithelial barriers through M cell-mediated transcytosis, followed by 333 
dissemination to epithelial cells from the basolateral side (Carayol and Tran Van Nhieu, 334 
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2013; Cossart and Sansonetti, 2004; Phalipon and Sansonetti, 2007). Our findings 335 
provide a compelling alternative hypothesis that secreted HD5 enables a mode of direct 336 
and active invasion by Shigella from the apical surface of the intestinal epithelium. We 337 
propose that Shigella, while in transit, encounters HD5 molecules in the small intestine 338 
and becomes highly adhesive and invasive as it reaches more distal sites in the colon. 339 
Since HD5 is expressed by Paneth cells in the small intestine (Bevins and Salzman, 340 
2011), its high local concentration at the luminal surface of the small intestine is likely 341 
lethal to Shigella, which might then largely restrict bacterial adhesion and invasion to the 342 
downstream colonic epithelium where HD5 is greatly reduced in abundance. Moreover, 343 
the finding that Concanavalin A, a lectin that interacts with diverse host proteins 344 
containing mannose carbohydrates, failed to inhibit HD5-enhanced Shigella infection in 345 
vitro suggests a limited role played by mucin and/or surface glycoproteins in attenuating 346 
this HD5 activity in vivo. This direct invasion model reinforces a recent finding that 347 
Shigella primarily targets colonic crypts during the initial stages of mucosal invasion 348 
(Arena et al., 2015). 349 
It is plausible that Shigella may have undertaken a different evolutionary 350 
trajectory from Salmonella or E. coli to manifest its pathogenicity. Hijacking a host 351 
innate immune molecule to facilitate bacterial adhesion and invasion might provide 352 
evolutionary advantage for Shigella, as lack of adhesive appendages such as fimbriae 353 
or flagella (Bravo et al., 2015) should help the pathogen evade host immune 354 
surveillance and thrive in the gut with significantly less anabolic burden. However, such 355 
a strategy that depends on a specific host factor would restrict host range, especially 356 
when targeting an epithelial α-defensin, where primary structures vary markedly from 357 
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species to species. While it is not unusual for a microbial pathogen to exploit host 358 
components to promote its pathogenicity, our findings contribute a striking example of 359 
this phenomenon.  360 
In addition, human neutrophil granular proteins containing α-defensins HNPs 1-4 361 
can enhance Shigella adhesion in vitro at sub-lethal concentrations (Eilers et al., 2010), 362 
in accordance with our results on HNP1. Furthermore, both HD5 and HD6 have been 363 
reported to enhance HIV-1 infectivity in vitro by promoting virion attachment to target 364 
cells (Rapista et al., 2011). However, both the molecular mechanisms and physiological 365 
implications of those findings remain to be determined. A very recent report found that a 366 
mouse adenovirus to promotes its host entry in a receptor-independent manner by 367 
binding to mouse alpha-defensins (cryptdins), resulting in enhanced enteric viral 368 
infection (Wilson et al., 2017) and suggesting that pathogen exploitation of defensins for 369 
infection is not restricted to humans. 370 
The precise molecular details underlying HD5-enhanced Shigella adhesion to 371 
epithelial cells and tissues need to be further clarified. HD5 is capable of binding to 372 
diverse molecular, bacterial and viral targets in a multivalent, somewhat promiscuous 373 
fashion (Lehrer et al., 2009; Lehrer and Lu, 2012; Rajabi et al., 2012; Tenge et al., 374 
2014). It may serve as a bridging molecule to directly crosslink bacterial and host cells 375 
as reported for HD5 and other mammalian defensins (Lehrer et al., 2009; Leikina et al., 376 
2005). Alternatively, by clustering Shigella cells, HD5 could endow the pathogen with a 377 
much-enhanced ability to adhere through multivalent high-avidity interactions between 378 
bacterial and host surface proteins. Cell-cell contact activates the T3SS, leading to 379 
Shigella invasion orchestrated by bacterial virulent effector proteins delivered by the 380 
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T3SS into host cells (Cossart and Sansonetti, 2004; Donnenberg, 2000; Hauser, 2009; 381 
Pizarro-Cerdá and Cossart, 2006). In the absence of an efficient host-adhesion 382 
apparatus of its own, HD5-promoted Shigella adhesion and colonization could 383 
potentiate T3SS activation, thus indirectly facilitating bacterial invasion and infection. 384 
Whether or not HD5 is capable of directly enabling Shigella invasion remains to be 385 
examined, though. Of note, shortening the LPS of Shigella increases accessibility of its 386 
T3SS tip to the host cell surface, thus augmenting T3SS activation and bacterial 387 
invasion (West et al., 2005). Although HD5 did not target LPS directly to promote 388 
adhesion, the possibility that HD5 perturbs the LPS structure for enhanced T3SS 389 
activation and Shigella invasion cannot be formally excluded. 390 
Finally, although Shigella is highly infectious in humans at an extremely low 391 
inoculum, it does not readily infect other animals. In fact, no suitable animal model is 392 
available to accurately recapitulate the pathogenesis of Shigella (Phalipon and 393 
Sansonetti, 2007). Mice express abundant quantities of α-defensins (cryptdins) in the 394 
intestine (Ouellette, 2011), yet they are relatively very resistant to oral Shigella 395 
challenge.  While this resistance may be due at least in part to the lack of IL-8 (Singer 396 
and Sansonetti, 2004), the finding that mouse cryptdins, in contrast to HD5, are 397 
incapable of promoting Shigella adhesion and colonization suggests an alternative 398 
explanation for host specificity of this important human enteropathogen. Whether the 399 
lack of expression in other animals of an ortholog of HD5 capable of enhancing Shigella 400 
pathogenesis is sufficient to confer resistance to infection warrants additional 401 
investigation. 402 
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FIGURE LEGENDS 631 
Fig. 1. HD5 promotes Shigella infection of epithelial cells in vitro. (A, B) The effects 632 
of eight antimicrobial peptides at sub-lethal concentrations on Shigella flexneri Sf301 633 
adhesion (A) to and invasion (B) of HeLa cells during bacterial infection. (C, D) The 634 
effects of HD5 treatment on Sf301 invasion (C) and proliferation (D) when added during 635 
initial infection (co-incubation) or after invasion (post-infection). Adhesion, invasion and 636 
proliferation assays were performed as described in Methods. Experimental details are 637 
illustrated in Fig. S2. Data are shown as mean ± SD of at least three independent 638 
experiments. Statistical significance was calculated (for peptide-treated samples 639 
compared to vehicle controls (0 µM)) using a one-way ANOVA (Dunnett’s multiple 640 
comparison Test), and p values are as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. 641 
(E) Fluorescence microscopy (left panels) and scanning electron microscopy (right 642 
panels) analysis of Sf301 adhesion to HeLa cells in the absence (control) or presence of 643 
4 μM HD5 (MOI=50:1). GFP-expressing bacteria are green, β1 integrin is red, and 644 
nuclei are blue (DAPI). For fluorescent images, the scale bars represent 50 μm; for 645 
SEM images, the bars represent 10 μm.  (F) Confocal microscopy images of HeLa cells 646 
infected for 60 min with mCherry-labeled WT Sf301 harboring a GFP-expressing 647 
reporter plasmid (Campbell-Valois et al., 2014) in presence or absence of 4 μM HD5. 648 
HeLa cells are counterstained with DAPI, and GFP expression is induced upon 649 
activation of type 3 secretion system triggered by bacterial cell contact with the host. 650 
Note that red and green overlay gives rise to yellow. The scale bars represent 50 μm. 651 
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Fig. 2. HD5 promotes Shigella infection in vivo. (A) Sereny test of Shigella infection 653 
using guinea pigs. Hartley guinea pigs (6-8 weeks of age) were inoculated with 106 654 
CFU/eye of mid-log phase Sf301 either in the absence (n=15) and presence of HD5 655 
(either 4 μM (n=14) or 8 μM (n=14)). A control group (n=6) was inoculated with HD5 656 
alone (8 μM). Animals were observed and scored for the development of conjunctivitis 657 
over 7 consecutive days. Eye pathology was independently scored by three individuals 658 
(blinded to treatment group) on a scale of 0-3, grade 0 (no disease or mild irritation), 659 
grade 1 (mild conjunctivitis or late development and/or rapid clearing of symptoms), 660 
grade 2 (keratoconjunctivitis without purulence), and grade 3 (fully developed 661 
keratoconjunctivitis with purulence) as indicated in Fig. S3A. The data are 662 
representative of three independent experiments. Each point represents a single 663 
animal. Statistical significance compared with inoculation of 106 CFU in the absence of 664 
HD5 was determined using a Mann-Whitney test, *p < 0.05, **p < 0.01. Please also see 665 
Fig. S3A for daily scoring. (B-H) Colon infection model with guinea pigs. Hartley guinea 666 
pigs (6-8 weeks of age) were inoculated intrarectally by 1x108 CFU of HD5-treated (8 667 
µM), 1x108 CFU of mock-treated, 1x109 CFU of mock-treated GFP-expressing Sf301 or 668 
medium alone, with 20 animals in each of the three treatment groups and 8 in the 669 
negative control group. Animals were monitored for 48h, and the distal 10 cm of colon 670 
tissue from groups of euthanized animals was harvested for analysis at 4, 8, 24 and 48 671 
h post-challenge. (B) Confocal microscopy images of representative colon sections at 4 672 
h post-challenge, counterstained with DAPI. The scale bars represent 50 μm. Please 673 
also see Fig. S3B for images at 8h and 24h post-challenge. The ten most bacteria-674 
enriched fields from each experimental group were analyzed at 4 h (n=3), 8 h (n=3), 24 675 
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h (n=5) and 48 h (n=5) post-challenge, followed by automated enumeration of individual 676 
bacteria (C). Results are representative of three independent experiments and are 677 
shown as mean ± SD. Statistical significance in comparison with 1x108 CFU of mock-678 
treated group at each time point was calculated using a one-way ANOVA (Dunnett’s 679 
multiple comparison Test), and p values are as follows: *p < 0.05, **p < 0.01. (D) SEM 680 
analysis of bacterial infection of the colonic mucosa at 2h post-challenge. The scale 681 
bars represent 5 μm. (E) Histopathology analysis of representative colon sections at 24 682 
h and 48 h post-challenge by HE staining. The scale bars represent 100 μm. Colon 683 
histopathology scores at 24 h (F) or 48 h (G) (n=5, each) were assigned as follows: 0, 684 
intact colonic architecture, no acute inflammation or epithelial injury; 1, focal minimal 685 
acute inflammation; 2, focal mild acute inflammation; 3, severe acute inflammation with 686 
multiple crypt abscesses and/or focal ulceration; 4, severe acute inflammation, multiple 687 
crypt abscesses, epithelial loss, and extensive ulceration. Results are representative of 688 
three independent experiments. Indicated are mean ± SEM. Each point represents a 689 
single animal. Statistical significance in comparison with 1x108 CFU of mock-treated 690 
group was determined using a Mann-Whitney test, *p < 0.05, **p < 0.01. (H) Core body 691 
temperature of animals 48 h post-challenge. Results are representative of three 692 
independent experiments. Indicated are mean ± SD. Each point represents a single 693 
animal (n=9). Statistical significance between indicated groups was determined using a 694 
one-way ANOVA (Tukey’s multiple comparison Test), *p < 0.05, **p < 0.01. (I-J) Ileum 695 
and colon infection model in mice. For the colon lops (I), a small abdominal incision was 696 
made in fasted, anesthetized mice and two separate loops of colon were isolated by 697 
suture (2-3 cm in length). For each animal, one isolated colonic loop was instilled with 698 
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1x107 CFU of HD5-treated Sf301, and the second loop with mock-treated Sf301 (both in 699 
100 μl medium). For the ileal loop model (J), the same experimental approach was 700 
employed except that the two sutured loops were with the distal ileum. Two-hours post 701 
inoculation, mice were euthanized, and loops were harvested for quantitative 702 
fluorescence imaging of Shigella infection. The scale bars represent 50 μm. Results are 703 
shown as mean ± SD. Statistical significance in comparison with group challenged with 704 
1x107 CFU of mock-treated bacteria was calculated using a t-test, and "*" indicates p < 705 
0.05. 706 
 707 
Fig. 3. HD5 promotes Shigella infection ex vivo. (A) SEM analysis of the bacterial 708 
adhesion (red arrows) to human colonic mucosa 30 min after inoculation of 106 CFU 709 
Sf301 in the absence (control) and presence of HD5 (8 µM). The scale bars represent 710 
10 μm. (B) SEM analysis of bacterial invasion of human colonic tissue at 2 h post-711 
inoculation in presence of 8 µM HD5. Clustered bacteria are indicated by red circles in 712 
the upper panel (the scale bar represents 100 μm), and individual bacteria by red 713 
arrows in the lower panel (the scale bar represents 5 μm). (C, D) Analysis of 714 
histopathology of human colorectal explants 2 h after the inoculation either with or 715 
without Sf301 in either the absence or presence of HD5 (8 µM). Untreated (control) and 716 
HD5-treated specimens are included for comparison. Experimental details are 717 
described in Methods. Colon histopathology scores (C) were assigned as described 718 
above. Results are representative of three independent experiments. Indicated are 719 
mean ± SEM. Each point represents a colon sample. Statistical significance was 720 
determined using a Mann-Whitney test, *p < 0.05. Representative images of HE staining 721 
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(the scale bars represent 100 μm) and SEM analysis (the scale bars represent 500 μm) 722 
of colonic mucosa at 2h post-challenge are shown in D. Please also see Fig. S3C for 723 
experimental procedure.  724 
 725 
Fig. 4. (A-C) HD5 potentiates destruction of the epithelium by Shigella. (A) Trans-726 
epithelial electrical resistance (TEER) analysis of epithelial integrity of the monolayer of 727 
polarized Caco-2 cells infected with Sf301 in either the absence or presence of HD5 (8 728 
µM). Percent TEER values were normalized against values of each treatment group at 729 
time 0. Data are mean ± SD from at least three independent experiments. Statistical 730 
significance was determined using a two-way ANOVA, **, p < 0.01; ***, p < 0.001. (B) 731 
Intracellular CFU of the polarized Caco-2 monolayer 6 h post-inoculation of Sf301 in 732 
either the absence or presence of HD5 (8 µM). Data are mean ± SD from at least three 733 
independent experiments. Statistical significance was determined using a t test ****, p < 734 
0.0001. (C) Disruption of the tight junction (as shown by immunofluorescence) and 735 
impairment of the integrity (as shown by SEM) of the epithelium. Polarized Caco-2 cells 736 
grown in transwell inserts were infected with Sf301 in either the absence or presence of 737 
HD5 (8 µM) for 6 h, followed by immunostaining with antibody against the tight junction 738 
marker ZO-1 (green). Nuclei are stained with DAPI (blue).  The scale bars represent 50 739 
μm. Invading bacteria in the polarized Caco-2 monolayer are indicated by red arrows in 740 
the SEM image. The scale bars represent 2 μm. (D, E) Effects of concentrated ileal fluid 741 
aspirates on Shigella Sf301 adhesion (D) and invasion (E) in comparison with DMEM 742 
either without or with HD5 (4 µM). Anti-HD5 antiserum was added to ileal fluids and 743 
HD5-containing DMEM at a dilution titer of 1:100 to examine its neutralizing activity 744 
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against Shigella infection promoted by endogenous HD5. Data are shown as mean ± 745 
SD of at least three independent experiments. Statistical significance between indicated 746 
groups was determined using a one-way ANOVA (Tukey’s multiple comparison test), 747 
and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. 748 
 749 
Fig. 5. Structural determinants of HD5 function. (A, B) Activities of native and 750 
alanine mutants of HD5 (A) and Abu-HD5 (B) on Shigella adhesion and invasion (for 751 
one hour). The adhesion and invasion assays were as in Fig. 1A, and data are 752 
expressed as the number of intracellular (A, B) and adhering (B) bacteria in HeLa cells 753 
relative to the input. Data are shown as mean ± SD of at least three independent 754 
experiments. Statistical significance in comparison with wildtype HD5 in A and in 755 
comparison with solvent control group in B was determined using a one-way ANOVA 756 
(Dunnett’s multiple comparison Test), and p values are as follows: *p < 0.05, **p < 0.01, 757 
***p < 0.001. (C, D) The 2Fo-Fc electron density map contoured at 1.0σ of molecule A 758 
of Y27A-HD5 (C) and R28A-HD5 crystal (D) and the superimposition of defensin 759 
molecules present in the asymmetric units of analogs’ crystals with the wildtype HD5 760 
monomers (shown in grey, from PDB code: 1ZMP (Szyk et al., 2006)). Side chains of 761 
cysteines forming disulfide bridges and mutated residues are shown as sticks.  762 
Structural analysis of Y27A-HD5 and R28A-HD5 analogs confirms that both mutant 763 
monomers assume the same fold as the wildtype HD5 monomer with no major changes 764 
to the overall structure and the network of three disulfide bridges. When superimposed, 765 
the root-mean-square deviations (RMSD) between 128 equivalent main chain atoms of 766 
wildtype HD5 and Y27A-HD5 and R28A-HD5 are in the range of 0.91-1.33 Å and 0.35-767 
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0.95 Å, respectively. (E, F) Crystal structures of the Y27A-HD5 monomer (E, green) and 768 
the R28A-HD5 dimer (F, yellow) superimposed on the wildtype HD5 dimer in grey (PDB 769 
code: 1ZMP). Mutated residues and alanine substitutions are shown as spheres. (G) 770 
Key functional residues of HD5 forming putative binding surfaces for interactions with 771 
bacterial and host proteins. Positively charged Arg28 residues are colored in blue, and 772 
hydrophobic residues Leu16, Val19, and Leu26 in green. Shades of green depict 773 
differences in activity with residues in light green being less important than those in dark 774 
green. Important residues not depicted in this view are Tyr27 and Leu29. 775 
 776 
Fig. 6. Bacterial determinants of HD5-promoted Shigella infection. (A) TEM 777 
analysis of fimbriae expression in Sf301. The Fim cassette from E. coli JM103 was 778 
expressed from arabinose-inducible pBAD vector in Sf301. The scale bars represent 1 779 
μm.  (B) Influence of fimbriae-expression on the adhesion and invasion of Sf301 in the 780 
absence or presence of HD5. Data are shown as mean ± SD of at least three 781 
independent experiments. Statistical significance was determined using a two-way 782 
ANOVA, and p values are as follows: *p < 0.05, **p < 0.01 and ***p < 0.001. (C) Host 783 
cell-adhesion activity of fimbriated and non-fimbriated E. coli strains in the absence or 784 
presence of HD5. Adhesion assays to HeLa cells were carried out with fimbriated E. coli 785 
(JM103), its fimbriaedeficient mutant (JM103 Δfim) and non-fimbriated E. coli (BL21). 786 
TEM images of these strains are shown on the right panel. The scale bars represent 787 
500 nm. Statistical significance between indicated groups was determined using a t test, 788 
and p values are as follows: *p < 0.05, **p < 0.01 and ***p < 0.001. (D) Either Sf301 789 
bacteria, or the HeLa cells, were pre-treated with HD5 at the indicated concentrations 790 
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for 30 min, washed once with DMEM, and the adhesion and invasion assays were 791 
performed. Data are shown as mean ± SD of at least three independent experiments. 792 
Statistical significance compared with solvent control (0 μM) group at each time point 793 
was determined using a one-way ANOVA (Dunnett’s multiple comparison test), and p 794 
values are as follows: *p < 0.05, **p < 0.01, and ***p < 0.001.  (E) SEM and TEM 795 
analysis of Sf301 treated with HD5 or its linear analogue (Abu-HD5). The scale bars 796 
represent 2 μm for SEM and 500 nm for TEM. (F) Immunogold-TEM analysis of HD5 797 
localization in Sf301-HeLa interaction in presence of HD5. HD5 was labeled by ~12 nm 798 
colloidal gold particles and TEM were performed as described in Methods. B, bacterium; 799 
C, Cell. The scale bars represent 500 nm. Please also see Fig. S5B for more 800 
Immunogold-TEM images showing HD5 bridging single bacterium to host and HD5 801 
clustering multiple bacteria. (G) Relative adhesion ability of different Sf301 mutants in 802 
the presence of 4 μM HD5. spa33, icsA, ompA, ompC, ompF genes and some 803 
combinations of two were ablated as described in Methods. Shigella strains were 804 
transformed with pBAD plasmids carrying the OmpC coding sequence and induced with 805 
10 mM L-arabinose for OmpC expression. Please also see Fig. S6F for SDS-PAGE 806 
analysis of the genetic ablations and recompletions. Adhesion assays were performed 807 
as in Fig. 1A. Data are normalized to the input and shown as the percentage of the 808 
adherent bacteria of wild-type Sf301 in the presence of 4 μM HD5. Data are shown as 809 
mean ± SD of at least three independent experiments. Statistical significance compared 810 
with wild type was determined using a one-way ANOVA (Dunnett’s multiple comparison 811 
test), and p values are as follows: *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.  812 
  813 
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STAR Methods section 814 
Wuyuan Lu (wlu@ihv.umaryland.edu) is the lead contact author responsible for 815 
providing reagents upon request. 816 
Ethics Approval 817 
All the animals used in this study were acquired from the Experimental Animal Center of 818 
Xi'an Jiaotong University. The animal studies were approved by the Committee on 819 
Animal Research and Ethics, Xi’an Jiaotong University. All the animals were maintained 820 
in animal care facilities in the School of Life Science and Technology, and provided with 821 
food and water ad libitum. The use of healthy colonic tissues from patients undergoing 822 
surgery for colon cancer and the use of human small intestinal fluid aspirates from 823 
healthy donors undergoing routine screening colonoscopy were approved by the Ethics 824 
Committee of the Second Affiliated Hospital of Xi’an Jiaotong University School of 825 
Medicine. Informed consent was obtained from all patients 826 
 827 
Reagents 828 
All peptides used in this study were chemically synthesized, correctly folded and highly 829 
purified as previously described (Pazgier et al., 2013; Rajabi et al., 2012; Szyk et al., 830 
2006; Wei et al., 2010; Wu et al., 2004; Wu et al., 2003). Anti-human integrin β1 831 
monoclonal antibody (MAB1959Z, P5D2) and anti-human integrin α5β1 monoclonal 832 
antibody (MAB1969, JBS5) were purchased from Millipore. Anti-human integrin β5 833 
monoclonal antibody (#3629, D24A5) was purchased from Cell Signaling Technology. 834 
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All common chemicals and reagents were purchased from Sigma-Aldrich unless 835 
indicated otherwise. 836 
 837 
Bacterial strains 838 
Bacterial strains used in this study are listed in Table S2. Shigella strains were cultured 839 
aerobically at 37 °C in Tryptic Soy (TS) broth (Aoboxing, Beijing, China) or on TS agar 840 
plates with addition of 0.1% Congo Red. E. coli strains in this study were cultured in 841 
Luria-Bertani (LB) broth (Aoboxing, Beijing, China) or on LB agar plates. Antibiotics 842 
(Sigma) were used as follows: ampicillin 200 μg/ml; kanamycin 100 μg/ml. 843 
 844 
Strain construction 845 
Genetic ablation of Bacterial genes was performed using the λ Red recombination 846 
system (Datsenko and Wanner, 2000). Briefly, bacterial cells transformed with pKD46 847 
were grown in the presence of L-arabinose to induce the expression of the lambda Red 848 
recombinase. A linear PCR product, amplified using the primers listed in Table S2, 849 
containing a kanamycin-resistance cassette (KRC) flanked by FLP and 50 bp of the 5’- 850 
and 3’-end homologous sequences of the target gene was electroporated into the 851 
bacterial cells and kanamycin was used to select the transformants. The plasmid pKD46 852 
was eliminated by incubation at 37 °C. To cure the kanamycin maker, pCP20 was 853 
introduced into kanamycin-resistant cells to elicit the recombination of flanking FLP 854 
sequences at both ends of the kanamycin cassettes. PCR screening for cured colonies 855 
were performed using specific primers listed in Table S2. For OmpC and fimbriae re-856 
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expression experiments, the OmpC coding sequence from Sf301 and the fimbriae-857 
expression cassette from E. coli JM103 (encoding FimA, I, C, D, F, G, H) were 858 
separately cloned into Nco I and Xho I sites of pBAD vector using the primers listed in 859 
Table S2. Bacterial cells transformed with pBAD-OmpC or pBAD-Fim were cultured in 860 
LB with 10 mM L-arabinose to induce the expression of OmpC or production of fimbriae 861 
in Sf301. 862 
 863 
Bactericidal assays 864 
Different bacterial strains (~106 CFU) were treated with the indicated concentrations of 865 
peptide in 500 μl DMEM (without serum) for 40 min at 37 °C with mild agitation. After 866 
washing, the bacteria were diluted and plated. Bacterial viability was determined by 867 
colony counting and normalized against the viability observed with mock (PBS) 868 
treatment. Results are reported as the mean percentage of input bacteria of three 869 
independent experiments ± SD. 870 
 871 
In vitro adhesion and invasion assay 872 
The cell lines and their culture medium used in this study are listed in Table S1. One 873 
day before the assays, cells were seeded into 24-well plates at a density of ~105 cells 874 
per well. One hour before the infection, cell culture medium was changed into serum-875 
free medium and ~106 CFU Sf301 from mid-exponential phase was added to the cells 876 
together with a titration of HD5 (0-8 μM). Bacteria were centrifuged (2000 rpm, 10 min, 877 
RT) onto HeLa cells (MOI 10:1, or indicated MOI) to synchronize the infection. For the 878 
 37 
adhesion assay, after washing, the cells were lysed with 0.1 % Triton/H2O and the CFU 879 
were enumerated after plating. For invasion and proliferation assays, bacteria/HeLa 880 
mixtures were incubated for 40 min after centrifugation and then washed, treated with 881 
gentamicin-containing (25 μg/ml) medium for another 1 hour (invasion) or 4 hours 882 
(proliferation) before being lysed for plating. Adhesion was defined as the total number 883 
of HeLa cell-associated bacteria and is shown as the percentage of input. Invasion and 884 
proliferation were defined as the total number of intracellular bacteria in cells 885 
(extracellular bacteria were killed by gentamicin, a cell-impermeable antibiotic). Average 886 
results of three independent experiments are reported as mean ± SD. For pre-treatment 887 
experiments, cells or bacteria were pre-incubated with HD5 at the indicated 888 
concentrations for 30 min, washed once with DMEM and then mixed to allow infection. 889 
Adhesion assays, invasion assays and proliferation assays were performed as stated 890 
above. Schematic illustration of the assays is shown in Fig. S2. 891 
 892 
Sereny test 893 
Female specific pathogen-free Hartley guinea pigs, aged 6–8 weeks, weighing 120–250 894 
g, were inoculated via conjunctival route with 106 CFU/eye of mid-log phase Sf301 in 895 
the absence or presence of 4 μM or 8 μM HD5 as described (Labrec et al., 1964), with 896 
15 animals in each group. The protocol was approved by the Committee on Animal 897 
Research and Ethics of Xi’an Jiaotong University. Inoculated animals were observed 898 
and scored for 7 consecutive days for the development of conjunctivitis. Eye tissues 899 
were scored by three individuals (DX, YS, YC) who were kept unaware of the treatment 900 
group on a scale of 0-3 defined as follows: grade 0 (no disease or mild irritation), grade 901 
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1 (mild conjunctivitis or late development and/or rapid clearing of symptoms), grade 2 902 
(keratoconjunctivitis without purulence), grade 3 (fully developed keratoconjunctivitis 903 
with purulence). Statistical significance was calculated using a Mann-Whitney test.  904 
 905 
Colon infection model in guinea pigs 906 
Female pathogen-free Hartley guinea pigs, aged 6–8 weeks, weighing 120–250 g, were 907 
fasted for 24 h and anesthetized by intraperitoneal injection of nembutal (30 mg/kg). 908 
Animals were inoculated intrarectally with either 1x108 CFU of HD5-treated, 1x108 CFU 909 
of mock-treated (low-inoculum positive control) or 1x109 CFU (high-inoculum positive 910 
control) of mock-treated GFP-expressing Sf301 in 200μl medium. Animals inoculated 911 
with medium containing 8μM HD5 at equal volume served as negative controls. HD5-912 
treated Shigella bacteria were prepared as following: 1x108 CFU of Sf301 were 913 
incubated with 8μM HD5 in 50ml DMEM for 20 minutes followed by centrifugation for 914 
10-min. Most supernatant was decanted, leaving 200 μl to resuspend the bacteria. 915 
Temporally representative samples from colonic tissues were obtained at 4, 8, 24 and 916 
48h post-intrarectal challenge by euthanizing animals using nembutal. The distal 10 cm 917 
of colon was harvested and flushed with 4% (vol/vol) paraformaldehyde (PFA) in 918 
1×PBS, inverted on wooden skewers, and kept in 4% PFA 1×PBS for 1–2 h to complete 919 
fixation of the tissue and then incubated in 1×PBS glycine (100 mM) for 30 min to 920 
quench the PFA. Tissues were then immersed successively in 15% and 30% (wt/vol) 921 
sucrose at 4 °C overnight. Tissues were removed from the skewers by a longitudinal 922 
incision and prepared as Swiss rolls (Arena et al., 2015). Swiss rolls were then 923 
embedded in Tissue-Tek OCT compound (Sakura) using a flash-freeze protocol and 924 
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frozen at −80 °C. These OCT-frozen tissue preparations were cut as 20-μm-thick 925 
transversal sections. Tissues on slides were fixed with 4% PFA for 10 min at room 926 
temperature and permeabilized in PBS/0.2% Triton X-100 for 10 min. The slides were 927 
washed, mounted with Anti-Fade solution (Invitrogen) containing DAPI onto glass slides 928 
and visualized under a Zeiss confocal microscope. Shigella infection foci were identified 929 
by GFP fluorescence microscopy. The ten most bacteria-enriched fields from each 930 
group were analyzed, followed by automatic enumeration of individual Shigella bacteria 931 
using ImageJ 1.51k software (from http://imagej.nih.gov/ij).  932 
 933 
Murine ileal and colonic loop 934 
Eight-week-old pathogen-free Balb/c mice (weight 20–30 g) were fasted for 24 h and 935 
anesthetized by intraperitoneal injection of nembutal (60 mg/kg). While maintaining the 936 
body temperature at 37o using a heating pad, a small abdominal incision was made and 937 
two adjacent loops of either distal ileum or colon were isolated by suture (2–3 cm in 938 
length) in each animal. For each animal, one loop was instilled with 1x107 CFU of HD5-939 
treated Sf301 (GFP-expressing), and the other was instilled with mock-treated Sf301 940 
(both in 100 μl medium). HD5-treated Shigella bacteria were prepared as following: 941 
1x107 CFU of Sf301 were incubated with 8μM HD5 in 5ml DMEM for 20 minutes 942 
followed by centrifugation for 10-min. Most supernatant was decanted leaving 100 μl to 943 
resuspend the bacteria. The ileum (or colon) tissues were obtained at 2h post-944 
inoculation, processed and analysized as described above for the colon infection model 945 
of guinea pigs.  946 
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 947 
Human small intestinal fluid aspirates 948 
Ileal aspirates were obtained from healthy individuals who were undergoing routine 949 
screening colonoscopy for colon polyps. Prior to colonoscopy (~24h beforehand), 950 
patients were administered a routine polyethylene glycol-electrolyte solution to purge 951 
the bowel of contents, and the patients remained on clear fluids until the procedure was 952 
completed. During the colonoscopy procedure, the terminal ileum was intubated. 953 
Approximately 5-15 ml of ileal lumenal fluid was aspirated and immediately placed on 954 
ice. Specimens were clarified by centrifugation and filtered through a 0.22 μm filter.  For 955 
some specimens, the fluid was further concentration by centrifugal filtration.  The 956 
aliquots were stored in a freezer at -80o prior to analysis. The clarified fluid was used as 957 
the medium for Shigella infection assays. 958 
 959 
Human colorectal explants 960 
The human colorectal explants were established in accordance to a protocol recently 961 
developed by Tisilingiri et al. (Tsilingiri et al., 2012). Briefly, healthy colonic tissues were 962 
obtained from patients undergoing surgery for colon cancer. Tissue samples, 963 
maintained in Hank’s balanced salt solution on ice, were transported to the laboratory 964 
and processed within two hours. The mucosa layer was separated from the underlying 965 
tissues, and then divided into pieces (~2-3 cm by ~2-3 cm) and placed on soft agar (1% 966 
in PRMI 1640 medium) with the mucosal surface facing upward. A sterile cylinder (8 967 
mm in inner diameter) was used to remove small pieces of soft agar under the center of 968 
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the tissue segments and fresh medium was added to the small holes so that a small dip 969 
was formed at the center of the segment (Fig. S3C).  An aliquot (5x105 CFU) of Shigella 970 
from logarithmic growth culture in 10 μl of PRMI 1640 medium was added to the dip of 971 
the colon tissue and the explants were cultured in medium with or without 8μM HD5 at 972 
37 °C for various times (from 30 min to 2 hours) in a cell culture incubator. Bacteria-free 973 
segments served as negative controls for each experiment and time point. Following 974 
incubation, infected explants were fixed in 10% buffered formalin, paraffin embedded 975 
and HE-stained for histopathological examination. 976 
 977 
Measurement of trans-epithelial electrical resistance (TEER) 978 
Caco-2 cells (3X104 cells per well) were grown on 24-well transwell inserts with a 0.4 979 
μm pore size (Corning) in 10% FBS DMEM. Five days after seeding, the polarized cells 980 
were placed in serum-free DMEM, and an aliquot of Sf301 bacteria (MOI=50:1) was 981 
inoculated to the apical chamber either with or without HD5. The infected CaCo-2 cells 982 
were incubated for 60 min and then washed, treated with gentamicin-containing (50 983 
μg/ml) medium. TEER values of the polarized epithelial monolayer were measured by 984 
Millicell ERS-2 Voltohmmeter (Merck Millipore) for 24 hours. Monolayers with TEER 985 
values within ,800–1200 Ω.cm2 were considered to have an appropriate barrier function 986 
and were used in the study. 987 
 988 
Crystallization, Data collection and Structure Determination  989 
Lyophilized HD5 mutant proteins were dissolved in water (20 mg/ml), mixed in a 1:1 990 
ratio with precipitant solutions composed as listed in Table S4 and equilibrated at 22o in 991 
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a hanging drop crystallization format. Crystals were flash frozen in liquid nitrogen after a 992 
brief soak in cryoprotectant solution (Table S4). Data were collected at the Stanford 993 
Synchrotron Radiation Light Source (SSRL) beamlines BL7-1 (Y27A mutant crystal form 994 
1) and BL12-2 (Y27A mutant crystal form 2 and the R28A mutant).  All data were 995 
processed and reduced with HKL2000 (Otwinowski and Minor, 1997).  Structures were 996 
solved by molecular replacement with the program Phaser (McCoy et al., 2007) from 997 
the CCP4 suite based on the coordinates of the 1ZMP wild type HD5 monomer (Szyk et 998 
al., 2006).  Refinement was carried out with Refmac (Murshudov et al., 1997) and/or 999 
Phenix (Adams et al., 2010) and model building was done with COOT (Emsley et al., 1000 
2010). Data collection and refinement statistics are shown in Table S5. Ramachandran 1001 
statistics were calculated with Molprobity (Chen et al., 2010) and illustrations were 1002 
prepared with Pymol Molecular graphics (http://pymol.org).  Crystallographic data were 1003 
collected at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of 1004 
SLAC National Accelerator Laboratory and an Office of Science User Facility operated 1005 
for the U.S. Department of Energy Office of Science by Stanford University. The SSRL 1006 
Structural Molecular Biology Program is supported by the US Department of Energy 1007 
Office of Biological and Environmental Research, by the National Institutes of Health 1008 
(NIH) National Center for Research Resources, Biomedical Technology Program 1009 
(P41RR001209), and by the National Institute of General Medical Sciences. 1010 
 1011 
Immunofluorescence microscopy 1012 
Cells were plated onto glass coverslips and adhesion assays were performed as 1013 
described using Sf301 harboring the GFP-expressing plasmid. Cells were fixed in 3% 1014 
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paraformaldehyde at room temperature for 15 min followed permeablization with 1015 
0.1%Trtion (in PBS) for 3-5min, washed in PBS and blocked with 5% BSA (in PBS) for 1016 
30 min at room temperature. The coverslips were incubated with Actin, α5β1 or β1 1017 
antibodies at 4 °C overnight followed by PBS washing and incubation with Alexa Fluor 1018 
594 secondary antibody (Invitrogen Molecular Probes, Carlsbad, CA) for 1 h. The 1019 
coverslips were washed, mounted with Anti-Fade solution (Invitrogen) containing DAPI 1020 
onto glass slides and visualized under Zeiss confocal microscope.  1021 
 1022 
Electron microscopy 1023 
For scanning electron microscopy (SEM), adhesion assay was performed in the 1024 
presence of 4 μM HD5 (MOI 50:1) as described above. Cells were fixed with 1025 
paraformaldehyde (15min) and glutaraldehyde (overnight). The fixed specimens were 1026 
dehydrated in graded ethanol, critical point dried with CO2 and coated with gold-1027 
palladium beads with a diameter of 15 nm. Samples were photographed using a Philips 1028 
XL-30 scanning electron microscope at 20 kV. 1029 
For transmission electron microscopy (TEM), bacteria (treated with or without HD5) 1030 
were stained with 1.5% phosphotungstic acid for 90s and examined by TEM (H-7650, 1031 
HITACHI). 1032 
For immunogold-TEM, the adhesion assay was performed in the presence of 4 μM HD5 1033 
(MOI 50:1) as previously described. Cells were fixed in 3% paraformaldehyde at room 1034 
temperature for 15 min followed permeablization with 0.1%Trtion (in PBS) for 3-5min, 1035 
washed in PBS and blocked with 5% BSA (in PBS) for 30 min at room temperature. 1036 
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Cells were then incubated with rabbit anti-HD5 antibody at 1:100 dilution at 4 °C 1037 
overnight, followed by PBS washing and incubation with 12nm colloidal gold-conjugated 1038 
donkey anti-rabbit IgG (H+L) for 2h at room temperature. Cells were washed and further 1039 
fixed in 3% paraformaldehyde at room temperature for 15 min. Cells were collected by 1040 
scratching and centrifugation. Further fixation was performed in 3% paraformaldehyde 1041 
and 0.25% glutaraldehyde at 4 °C overnight. Cell mass were embedded and cut into 1042 
ultrathin sections as described, colloidal gold particles were recognized as dark spots 1043 
under TEM (H-7650, HITACHI). 1044 
 1045 
siRNA silencing  1046 
The siRNA oligonucleotides were synthesized by Shanghai GenePharma (Shanghai, 1047 
China) and their sequences are shown in Table S6. Cells were transfected with siRNAs 1048 
according to the recommended procedures of LipofectamineTM2000 Transfection 1049 
Reagent (Invitrogen, Carlsbad, CA). 1050 
 1051 
Statistical analysis 1052 
The data were collected from at least three independent experiments in triplicate or 1053 
quadruplicate, unless otherwise indicated. Data were combined and represented as 1054 
mean ± SEM or mean ± SD as indicated. Results were analyzed by various statistical 1055 
tests using GraphPad Prism version 7. p < 0.05 was considered statistically significant. 1056 
Microscopy images are representative of at least two independent experiments. 1057 
 1058 
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Data availability 1059 
The data that support the findings of this study are available from the corresponding 1060 
author upon request. 1061 
